Sales rise 16.13% to Rs 194.07 crore
Net profit of ERIS Lifesciences rose 9.52% to Rs 57.50 crore in the quarter ended March 2018 as against Rs 52.50 crore during the previous quarter ended March 2017. Sales rose 16.13% to Rs 194.07 crore in the quarter ended March 2018 as against Rs 167.12 crore during the previous quarter ended March 2017.For the full year,net profit rose 18.34% to Rs 293.66 crore in the year ended March 2018 as against Rs 248.14 crore during the previous year ended March 2017. Sales rose 6.69% to Rs 760.60 crore in the year ended March 2018 as against Rs 712.90 crore during the previous year ended March 2017.
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales194.07167.12 16 760.60712.90 7 OPM %37.1933.19 -41.5338.03 - PBDT72.6562.13 17 333.69295.42 13 PBT64.8856.32 15 311.90273.98 14 NP57.5052.50 10 293.66248.14 18
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
